Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling
The use of a selective JAK3 covalent inhibitor reveals two distinct temporal waves of STAT5 phosphorylation. The inhibitor more potently targets the second wave, which is required for cell cycle progression and T cell proliferation. To drive lymphocyte proliferation and differentiation, common γ-cha...
Gespeichert in:
Veröffentlicht in: | Nature chemical biology 2016-05, Vol.12 (5), p.373-379 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The use of a selective JAK3 covalent inhibitor reveals two distinct temporal waves of STAT5 phosphorylation. The inhibitor more potently targets the second wave, which is required for cell cycle progression and T cell proliferation.
To drive lymphocyte proliferation and differentiation, common γ-chain (γ
c
) cytokine receptors require hours to days of sustained stimulation. JAK1 and JAK3 kinases are found together in all γ
c
-receptor complexes, but how their respective catalytic activities contribute to signaling over time is not known. Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i). By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4
+
T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave. Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase. An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice. Our chemical genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2–driven T cell proliferation and will find broad utility in studies of γ
c
-receptor signaling. |
---|---|
ISSN: | 1552-4450 1552-4469 |
DOI: | 10.1038/nchembio.2056 |